Arcadia Biosciences Files 8-K
Ticker: RKDA · Form: 8-K · Filed: May 16, 2025 · CIK: 1469443
| Field | Detail |
|---|---|
| Company | Arcadia Biosciences, Inc. (RKDA) |
| Form Type | 8-K |
| Filed Date | May 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory
TL;DR
Arcadia Biosciences filed an 8-K on May 16th, reporting events from May 14th. Check it for Reg FD, other events, and financials.
AI Summary
Arcadia Biosciences, Inc. filed an 8-K on May 16, 2025, reporting events as of May 14, 2025. The filing includes information on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company's principal executive offices are located in Dallas, Texas.
Why It Matters
This 8-K filing provides updates on significant company events and disclosures, which are crucial for investors to understand the latest developments at Arcadia Biosciences.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain immediate negative or positive news that would significantly alter the company's risk profile.
Key Players & Entities
- Arcadia Biosciences, Inc. (company) — Registrant
- May 14, 2025 (date) — Date of earliest event reported
- May 16, 2025 (date) — Date of report
- Dallas, Texas (location) — Address of Principal Executive Offices
FAQ
What specific events are disclosed under 'Other Events' in this 8-K filing?
The filing indicates 'Other Events' are reported, but the specific details of these events are not provided in the provided text excerpt.
What is the significance of the 'Regulation FD Disclosure' item?
Regulation FD (Fair Disclosure) requires public companies to disclose material non-public information to the public in a manner that prevents selective disclosure.
Where are Arcadia Biosciences' principal executive offices located?
Arcadia Biosciences' principal executive offices are located at 5950 Sherry Lane Suite 215, Dallas, Texas, 75225.
What is the Commission File Number for Arcadia Biosciences?
The Commission File Number for Arcadia Biosciences, Inc. is 001-37383.
When is the fiscal year end for Arcadia Biosciences?
Arcadia Biosciences' fiscal year ends on December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding Arcadia Biosciences, Inc. (RKDA).